Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis., Proceedings of the National Academy of Sciences, vol.59, issue.1, pp.94-101, 1968. ,
DOI : 10.1073/pnas.59.1.94
Epstein-Barr virus oncogenesis, Critical Reviews in Oncology/Hematology, vol.26, issue.2, pp.117-152, 1997. ,
DOI : 10.1016/S1040-8428(97)00016-4
Carcinomas of the nasopharynx in children. Analysis of 50 cases, Bull Cancer, vol.82, issue.2, pp.155-61, 1995. ,
Epidemiological descriptive approach of cancer in Morocco through the activity of the National Institute of Oncology, Bull Cancer, vol.78, pp.603-612, 1986. ,
Coupled transcription of Epstein--Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas, Journal of General Virology, vol.76, issue.1, pp.131-139, 1995. ,
DOI : 10.1099/0022-1317-76-1-131
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells, Cell, vol.43, issue.3, pp.831-871, 1985. ,
DOI : 10.1016/0092-8674(85)90256-9
Epstein???Barr virus latent membrane protein inhibits human epithelial cell differentiation, Nature, vol.344, issue.6268, pp.777-80, 1990. ,
DOI : 10.1038/344777a0
The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1, Proceedings of the National Academy of Sciences, vol.95, issue.7, pp.3621-3627, 1998. ,
DOI : 10.1073/pnas.95.7.3621
Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins, Cancer Res, vol.63, pp.256-62, 2003. ,
The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor, J Virol, vol.69, pp.4390-4398, 1995. ,
Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells, Proceedings of the National Academy of Sciences, vol.98, issue.12, pp.6905-6915, 2001. ,
DOI : 10.1073/pnas.121016998
Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death, Cell, vol.65, issue.7, pp.1107-1122, 1991. ,
DOI : 10.1016/0092-8674(91)90007-L
Expression of the Epstein-Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines, Cancer Res, vol.56, pp.4610-4613, 1996. ,
Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein- Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance, Journal of Experimental Medicine, vol.167, issue.6, pp.1811-1835, 1988. ,
DOI : 10.1084/jem.167.6.1811
Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-j B activation and to induction of cell surface markers, J Virol, vol.68, pp.5602-5614, 1994. ,
Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-j B/Rel family proteins, J Virol, vol.69, pp.4572-4578, 1995. ,
Role of the TRAF binding site and NF-jB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression, J Virol, vol.72, pp.7900-7908, 1998. ,
Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-jB activation, J Virol, vol.71, pp.586-94, 1997. ,
The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation, Proceedings of the National Academy of Sciences, vol.94, issue.4, pp.1447-52, 1997. ,
DOI : 10.1073/pnas.94.4.1447
Activation of the p38 Mitogen-activated Protein Kinase Pathway by Epstein-Barr Virus-encoded Latent Membrane Protein 1 Coregulates Interleukin-6 and Interleukin-8 Production, Journal of Biological Chemistry, vol.274, issue.23, pp.16085-96, 1999. ,
DOI : 10.1074/jbc.274.23.16085
Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade, The EMBO Journal, vol.16, issue.21, pp.6478-85, 1997. ,
DOI : 10.1093/emboj/16.21.6478
The Epstein- Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor j B, J Biol Chem, vol.267, pp.24157-60, 1992. ,
Latent membrane protein 1of Epstein-Barr virus interacts with JAK3 and activates STAT proteins, The EMBO Journal, vol.18, issue.11, pp.3064-73, 1999. ,
DOI : 10.1093/emboj/18.11.3064
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1171388
The Transmembrane Domains of the EBV-Encoded Latent Membrane Protein 1 (LMP1) Variant CAO Regulate Enhanced Signalling Activity, Virology, vol.282, issue.2, pp.278-87, 2001. ,
DOI : 10.1006/viro.2001.0828
Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population, Oncogene, vol.7, pp.2131-2171, 1992. ,
Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus, Oncogene, vol.12, pp.2129-2164, 1996. ,
Signature Amino Acid Changes in Latent Membrane Protein 1 Distinguish Epstein???Barr Virus Strains, Virology, vol.261, issue.1, pp.79-95, 1999. ,
DOI : 10.1006/viro.1999.9855
Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma, Journal of General Virology, vol.72, issue.10, pp.2399-409, 1991. ,
DOI : 10.1099/0022-1317-72-10-2399
Epstein-barr virus genotypes in NPC biopsies from North Africa, International Journal of Cancer, vol.228, issue.4, pp.468-73, 1994. ,
DOI : 10.1002/ijc.2910560403
Amino-acid change in the Epstein-Barr-virus zebra protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa, International Journal of Cancer, vol.14, issue.4, pp.497-503, 1998. ,
DOI : 10.1002/(SICI)1097-0215(19980209)75:4<497::AID-IJC2>3.0.CO;2-O
Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma, Journal of Virology, vol.78, issue.2, pp.868-81, 2004. ,
DOI : 10.1128/JVI.78.2.868-881.2004
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells, Nature, vol.369, issue.6479, pp.407-417, 1994. ,
DOI : 10.1038/369407a0
Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution, J Virol, vol.70, pp.2490-2496, 1996. ,
Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma, International Journal of Cancer, vol.5, issue.2, pp.294-301, 2001. ,
DOI : 10.1002/1097-0215(200102)9999:9999<::AID-IJC1177>3.0.CO;2-9
URL : https://hal.archives-ouvertes.fr/pasteur-00647025
Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells, Journal of Medical Virology, vol.31, issue.1, pp.63-72, 2002. ,
DOI : 10.1002/jmv.2112
Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1590, issue.1-3, pp.1-3150, 2002. ,
DOI : 10.1016/S0167-4889(02)00208-2
Mechanism of Action of a Novel Latent Membrane Protein-1 Dominant Negative, Journal of Biological Chemistry, vol.276, issue.2, pp.1195-203, 2001. ,
DOI : 10.1074/jbc.M005461200
Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in Tumors, Journal of Virology, vol.75, issue.6, pp.2929-2966, 2001. ,
DOI : 10.1128/JVI.75.6.2929-2937.2001
All three domains of the Epstein- Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts, J Virol, vol.67, pp.1638-1684, 1993. ,